In this episode of GEN's Touching Base, editors talk about neuroscience research updates, insights into how investors are approaching the changing AI landscape, and business updates on profits and buyouts. The post Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
Organ Aging Linked to Breakdown in Immune Cell...
Biogen’s mixed Alzheimer’s data; Two new startups...
Genetic Study Links Excessive Sweating to Neurological...
Parkinson’s in the Clinic, Insilico enters Phase...
KRAS-Targeted Vaccine Crosses First Clinical Milestone...
Gene Therapy Partners Aim to Enhance Protein Expression
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.